TNFRSF9 and cancer: The specificity was verified by evaluating the cytotoxic efficacy of ETAST isolated from the blood of patients with cancer against autologous cancer cells from tumor tissues; CD3+CD137+ ETASTs were isolated from the peripheral blood of two lungs of patients with cancer mTC NPs loaded with mixed lysates of seven lung cancer cell lines.